Nicotine Lozenge
Product Images NDC 41250-734

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nicotine (NDC 41250-734). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meijer Distribution Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

An instructional wallet card titled 'My most important reasons to quit smoking are:' with six blank lines for the user to write personal reasons for quitting smoking.*

FDA Label Image

Image 02

A wallet card listing contact phone numbers for quit-smoking support organizations, including the American Lung Association, American Cancer Society, and American Heart Association. The card also suggests calling a quitting buddy or friend who has quit smoking for help.*

FDA Label Image

Image 03

FDA Label Image

Image 04

FDA Label Image

Image 05

An instructional diagram showing a four-step reminder system for nicotine lozenge usage over weeks. Step 1, in red, advises 1 lozenge every 1 to 2 hours at the start of week 1. Step 2, in blue, recommends 1 lozenge every 2 to 4 hours at the start of week 7. Step 3, in black, suggests 1 lozenge every 4 to 8 hours at the start of week 10. The final green box marks 'EX-SMOKER' status 12 weeks after the quit date.*

FDA Label Image

Image 06

Nicotine Lozenge 2 mg mini lozenge by Meijer Distribution Inc, an OTC stop smoking aid with nicotine polacrilex. Mint flavored, available in a package of 81 lozenges divided into 3 mini QuitTubes of 27 lozenges each. The label includes warnings, usage instructions, and the barcode, emphasizing use with a support program and proof of age requirements.*

FDA Label Image

Image 07

Drug Facts text panels for Nicotine Polacrilex 2 mg lozenge by Meijer Distribution Inc. The panels include active ingredient, uses, warnings, directions with dosing schedule over 12 weeks, storage instructions, inactive ingredients, and contact information. Additional notes cover usage advice, potential side effects, and essential precautions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.